SCHEMBL20031344

SCHEMBL20031344

CC/N=C(\C)N1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.45
HTT P42858 2/20 0.42
TSHR P16473 2/20 0.42
ALDH1A1 P00352 2/20 0.40
PDK1 Q15118 2/20 0.40
PDK2 Q15119 2/20 0.40
PDK3 Q15120 2/20 0.40
FAAH O00519 1/20 0.40
PHGDH O43175 1/20 0.40
ALDH2 P05091 1/20 0.40
MGLL Q99685 1/20 0.40
RECQL P46063 1/20 0.39
POLB P06746 3/20 0.38
LMNA P02545 3/20 0.37
CA12 O43570 3/20 0.37
CA1 P00915 3/20 0.37
CA9 Q16790 3/20 0.37
CA2 P00918 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
MTOR P42345 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18731318 0.75 HTT (0.44) SMN1; SMN2HTTTSHRALDH1A1PDK1
SCHEMBL17236510 0.75 SMN1; SMN2 (0.50) SMN1; SMN2HTTTSHRALDH1A1PDK1
SCHEMBL19861950 0.75 SMN1; SMN2 (0.50) SMN1; SMN2HTTTSHRALDH1A1PDK1
SCHEMBL1105467 0.75 SMN1; SMN2 (0.50) SMN1; SMN2HTTTSHRALDH1A1PDK1
SCHEMBL21564657 0.74 CA2 (0.35) PHGDHCA12CA1CA9CA2
SCHEMBL19494552 0.74 HTT (0.39) SMN1; SMN2HTTTSHRALDH1A1PDK1
SCHEMBL22963103 0.72 CYP2D6 (0.33) TSHR
SCHEMBL21253643 0.71 HTT (0.37) SMN1; SMN2HTTTSHRALDH1A1PDK1
SCHEMBL17393247 0.70 SMN1; SMN2 (0.50) SMN1; SMN2HTTTSHRALDH1A1PDK1
SCHEMBL20706312 0.70 SMN1; SMN2 (0.45) SMN1; SMN2HTTTSHRALDH1A1PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018060174-A1 SUBSTITUTED BENZIMIDAZOLES, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND USE OF SAME TO PRODUCE DRUGS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-04-05 WO disclosed